Don't have a NovoMedLink account? Register now!

Diabetes themes

Key aspects of disease progression in type 2 diabetes are worsening glycaemic control and the increasing risk of micro- and macrovascular complications. Achieving HbA_1c targets can reduce the risk of complications, particularly microvascular complications, but glycaemic control may be complicated by weight gain associated with some glucose-lowering agents or psychosocial barriers. GLP-1 analogues may help type 2 diabetes patients reach their goals by regulating blood glucose and lowering weight.

General Diabetes The progression of type 2 diabetes and the need for intensification of therapy over time to reduce the risk of complications. Read more about diabetes progression >	Weight Management Weight control is key component of diabetes management, and improved glycaemic control often needs to be balanced with concerns about the weight gain associated with glucose-lowering therapy. Learn more about the importance of weight control >
Insulin Therapy Most patients with type 2 diabetes will eventually need insulin therapy to maintain adequate glycaemic control. Thus, insulin initiation and intensification may be needed to achieve HbA_1c goals. Explore insulin treatment >	Psychosocial Barriers Patients with diabetes face a significant burden of self-management. The Diabetes Attitudes Wishes and Needs (DAWN) study revealed that diabetes treatment should take into account psychosocial factors, in conjunction with appropriate medical management. Discover DAWN >
GLP-1 Basics GLP-1 deficiency is now recognized as a key component of type 2 diabetes. Learn how restoring GLP-1 levels can help patients manage their blood glucose, blood pressure and body weight. Read more about GLP-1 therapy in clinical practise >	Diabetes in Paediatric patients Children and adolescents diagnosed with type 1 diabetes have a great deal to gain from early and sustained diabetes control. Find out more about the importance of sustained glycaemic control in this patient population. Read more about paediatric diabetes >